APOE ɛ4 and Insulin Resistance Influence Path-Integration-Based Navigation through Distinct Large-Scale Network Mechanisms
aging and disease · 2024
DOI: 10.14336/ad.2024.0975 ↗Kurz gefasst
Fachartikel in der Zeitschrift aging and disease, 2024. Verfasst von Karel M Lopez-Vilaret und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Functional Neuroscience, Pablo de Olavide University, Seville, Spain. Hauptthemen laut MEDLINE: Apolipoprotein E4, Insulin Resistance, Spatial Navigation. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Functional Neuroscience, Pablo de Olavide University, Seville, Spain.
- CIBER de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
- Institute for Systems Neuroscience, Hamburg, Germany.
- Department of Neuropsychology, Institute of Cognitive Neuroscience, Faculty of Psychology, Ruhr University Bochum, Universitätsstraße 150, Bochum, Germany.
Zitieren
APA
Lopez-Vilaret, K. M., Fernandez-Alvarez, M., Bierbrauer, A., Axmacher, N., Cantero, J. L., & Atienza, M. (2024). APOE ɛ4 and Insulin Resistance Influence Path-Integration-Based Navigation through Distinct Large-Scale Network Mechanisms. aging and disease. https://doi.org/10.14336/ad.2024.0975
Vancouver
Lopez-Vilaret KM, Fernandez-Alvarez M, Bierbrauer A, Axmacher N, Cantero JL, Atienza M. APOE ɛ4 and Insulin Resistance Influence Path-Integration-Based Navigation through Distinct Large-Scale Network Mechanisms. aging and disease. 2024. doi:10.14336/ad.2024.0975
BibTeX
@article{LopezVilaret2024,
author = {Lopez-Vilaret, Karel M and Fernandez-Alvarez, Marina and Bierbrauer, Anne and Axmacher, Nikolai and Cantero, Jose L and Atienza, Mercedes},
title = {APOE ɛ4 and Insulin Resistance Influence Path-Integration-Based Navigation through Distinct Large-Scale Network Mechanisms},
journal = {aging and disease},
year = {2024},
doi = {10.14336/ad.2024.0975}
}
EUVIMED